文献速递心脑血管急症重症综合管理与镇静镇痛

高压氧治疗心肺复苏后缺氧缺血性脑损伤的多靶点机制与临床转化

[Multi-target mechanism and clinical transformation of hyperbaric oxygen therapy in the treatment of hypoxic-ischemic brain injury after cardiopulmonary resuscitation].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2025-01-01
一句话结论全球心脏骤停每年致死超300万例,复苏后存活率不足8%,其中68%死于缺氧缺血性脑损伤;高压氧通过抑制凋亡坏死、改善氧化应激、减轻神经炎症、增强血脑屏障通透性和侧支循环等多靶点机制发挥作用。

本文系统综述高压氧治疗心肺复苏后缺氧缺血性脑损伤的多靶点机制,包括抑制细胞凋亡和坏死、改善氧化应激、减少神经炎症、增强血脑屏障通透性和侧支循环。同时探讨高压氧联合肠道微生物调节和主动腹部加压-减压心肺复苏等新兴治疗策略,探索其作为复苏后缺氧缺血性脑损伤新治疗靶点的潜力,以期确定更有前景的临床转化路径,改善复苏后神经功能预后和生活质量。

要点

  • 全球心脏骤停每年致死超300万例,心肺复苏后存活率不足8%。
  • 缺氧缺血性脑损伤是68%心肺复苏后死亡病例的主要原因。
  • 高压氧通过增加血浆氧溶解、提高动脉血氧分压改善组织缺氧。
  • 高压氧治疗缺氧缺血性脑损伤的多靶点机制包括抑制细胞凋亡和坏死、改善氧化应激、减少神经炎症、增强血脑屏障通透性和侧支循环。
  • 高压氧联合肠道微生物调节和主动腹部加压-减压心肺复苏是新兴治疗策略,尚待临床转化研究。

适用人群与场景

  • 心脏骤停后恢复自主循环、存在缺氧缺血性脑损伤的患者。

研究设计与关键结果

  • 本文为综述,系统汇总高压氧治疗心肺复苏后缺氧缺血性脑损伤的多靶点机制:抑制细胞凋亡和坏死、改善氧化应激、减少神经炎症、增强血脑屏障通透性和侧支循环。
  • 文中探讨高压氧联合肠道微生物调节和主动腹部加压-减压心肺复苏作为新兴治疗策略的潜力。

证据类型、等级与局限

  • 证据类型:综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Cardiopulmonary resuscitation (CPR) is a critical life-saving intervention for patients who have suffered cardiac arrest (CA), which helps the organism of CA patients to rapidly restore respiratory and circulatory functions. However, the survival rate of patients after CPR is extremely low. Globally, sudden cardiac arrest causes over 3 million deaths annually, and the survival rate after CPR is less than 8%. Hypoxic ischemic brain injury (HIBI) is the primary cause of death in 68% of these cases. Hyperbaric oxygen therapy (HBOT) enhances the dissolution of oxygen in plasma, increases the arterial blood oxygen partial pressure in the body, and improves tissue hypoxia. It is widely used in conditions of cerebral ischemia and hypoxia (such as stroke, CA, etc), but its role in HIBI following CPR has not been fully studied. Therefore, this article systematically reviews the multi-target mechanisms of HBOT in the treatment of HIBI, including the inhibition of cell apoptosis and necrosis, improvement of oxidative stress, reduction of neuroinflammation, and enhancement of blood-brain barrier permeability and collateral circulation. It also discusses emerging treatment strategies such as HBOT combined with gut microbiome modulation and active abdominal compression-decompression CPR (AACD-CPR), exploring their potential as new therapeutic targets for HIBI post-CPR, with the aim of identifying more promising clinical translation paths to improve neurological functional prognosis and quality of life after CPR.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Huang Y, Yang X, Zhang S, et al. [Multi-target mechanism and clinical transformation of hyperbaric oxygen therapy in the treatment of hypoxic-ischemic brain injury after cardiopulmonary resuscitation]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 41500696. doi:10.3760/cma.j.cn121430-20250605-00317

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。